SAN DIEGO, Jan. 6, 2025 /PRNewswire/ -- Robbins LLP informs investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired AstraZeneca PLC (NASDAQ: AZN) securities between February 23, 2022 and December 17, 2024. AstraZeneca describes itself as "a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines in Oncology, Rare Diseases, and Biopharmaceuticals, including Cardiovascul ...

LOS ANGELES, Jan. 6, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against AstraZeneca PLC ("AstraZeneca" or "the Company") (NASDAQ: AZN) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between February 23, 2022 and December 17, 2024, inclusive (the "Class Period" ...

AstraZeneca (AZN) stock has declined 14% in the past three months. A lot of this price decline is due to ongoing investigations at its China subsidiary. However, the overall drug and biotech sector has also done poorly in the past three months after Trump announced the appointment of Robert F. Kennedy Jr., a vaccine skeptic, as the head of Health and Human Services, the agency that oversees the FDA.This, coupled with disappointing third-quarter sales and profits, guidance cuts and pipeline setbacks took a t ...

Novo Nordisk (NVO 0.15%) and AstraZeneca (AZN 0.56%) are among the largest companies in the pharmaceutical industry. Both have generally produced strong financial results in 2024, but one wouldn't know it by looking at their stock market performances. AstraZeneca's shares are down by 2% over the trailing-12-month period, while Novo Nordisk's shares are in the red by 14%.It just so happens that these drugmakers have encountered issues in recent months that sank their stock prices, although there is a good ch ...

NEW YORK, Jan. 3, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in AstraZeneca PLC ("AstraZeneca" or the "Company") (NASDAQ: AZN) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of AstraZeneca investors who were adversely affected by alleged securities fraud between February 23, 2022 and December 17, 2024. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/astrazeneca-plc-lawsuit- ...

NEW YORK, Dec. 30, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of AstraZeneca PLC (NASDAQ: AZN) between February 23, 2022 and December 17, 2024, both dates inclusive (the "Class Period"). A class action has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 21, 2025 in the securities class action first filed by the Firm.So what: If you p ...

NEW YORK, Dec. 30, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of AstraZeneca PLC (NASDAQ: AZN).Shareholders who purchased shares of AZN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE: https://securitiesclasslaw.com/securities/astrazeneca-plc-loss-submission-form-2/?id=118944&from=4 CLASS PERIOD: February 23, 2022 t ...

诉讼案件 - 针对AstraZeneca PLC的证券集体诉讼案件名为Saleh v AstraZeneca PLC et al 案件编号为24-cv-11021 [2] - 诉讼指控AstraZeneca及其部分高管在2022年2月23日至2024年12月17日期间未能披露重要信息 违反了联邦证券法 [1][7] 指控内容 - 公司在中国涉嫌保险欺诈 [5] - 由于上述行为 公司在中国面临更高的法律风险 导致AstraZeneca中国区总裁被中国执法部门拘留 [5] - 公司低估了其法律风险 [5] - 上述问题一旦曝光 可能对公司在中国业务活动造成重大损害 [5] - 被告关于公司业务 运营和前景的陈述在所有相关时间都存在重大虚假和误导性 或缺乏合理依据 [5] 投资者行动 - 投资者可在2025年2月21日前提交首席原告申请 [1] - 投资者可联系KSF管理合伙人Lewis Kahn 讨论其法律权利及案件对其经济损失赔偿权的影响 [4] 律所信息 - KSF是一家全国知名的精品证券诉讼律师事务所 合伙人包括前路易斯安那州总检察长Charles C Foti Jr [6] - KSF为包括公共机构投资者 对冲基金 资金管理公司和零售投资者在内的各类客户服务 寻求因上市公司欺诈或不当行为造成的投资损失赔偿 [6] - KSF在纽约 特拉华 加利福尼亚 路易斯安那 芝加哥和新泽西设有办公室 [6]

NEW YORK, Dec. 27, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  AstraZeneca PLC ("AstraZeneca" or the "Company") (NASDAQ: AZN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.The investigation concerns whether AstraZeneca and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On November 5, 202 ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.Zacks Premium includes access to the Zacks Style Sc ...